Food and Drug Administration Commissioner Marty Makary said in a recent interview he has no plans to change policies ...

FDA Commissioner Dr. Marty Makary joins Morning Joe to address the agency’s controversial decision to keep Juul e-cigarettes ...

Food and Drug Administration Commissioner Marty Makary said he has “no preconceived plans” to change the policies on ...

Commissioner Marty Makary said in an interview with Politico’s Dasha Burns that the FDA will “look at the data” surrounding ...

Mike Pence's think tank is asking the Food and Drug Administration to turn over documents related to the dangers of the ...

The FDA says access to Mifepristone will stay the same — despite safety reviews and pressure from some Republican lawmakers.

More than 50 biotech leaders and investors are urging the FDA to disregard a methodologically flawed report on mifepristone.

“It is highly concerning that the FDA is committed to a new review of mifepristone, given the massive amount of evidence on its safety and efficacy,” said Dr. Angel Foster, co-founder of the ...

The FDA is still on track to meet its user fee targets despite a higher-than-normal vacancy rate among scientific reviewers.

The FDA commissioner said access to mifepristone will stay the same, despite ongoing reviews of safety data and pressure from ...

The petition comes as FDA Commissioner Marty Makary promises a full agency review of the safety of the drug. The petitioners are urging the FDA to use the full review of mifepristone to lift ...

WEDNESDAY, July 16, 2025 (HealthDay News) — A federal appeals court has ruled that West Virginia can limit access to ...